Original Research

Cost-Effectiveness Analysis of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) versus FOLFOX-4 in Patients with RAS Wild-Type Metastatic Colorectal Cancer

Bai L, Zhang P, Zhou K, Liao W, Li Q

Cancer Management and Research 2019, 11:10419-10426

Published Date: 12 December 2019